AI
GILD icon

Arvest Investments’s Gilead Sciences GILD Stock Holding History

Arvest Investments’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-9,027
Closed -$1.01M – 177
2025
Q1 		$1.01M Sell
9,027
-1,435
-14% -$148K 0.16% 118
2024
Q4 		$966K Sell
10,462
-777
-7% -$70K 0.15% 115
2024
Q3 		$942K Buy
11,239
+107
+1% +$8.16K 0.14% 116
2024
Q2 		$764K Sell
11,132
-82
-0.7% -$5.47K 0.12% 115
2024
Q1 		$821K Sell
11,214
-166
-1% -$12.8K 0.13% 109
2023
Q4 		$922K Buy
+11,380
New +$886K 0.15% 103

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Arvest Investments's GILD Position: Q2 2025 in Review

Arvest Investments sold out of Gilead Sciences (GILD) in Q2 2025, closing a stake of 9,027 shares — an estimated $1.01M sold.

Arvest Investments first reported a position in GILD in Q4 2023 and held it in 6 quarters. The position peaked at $1.01M in Q1 2025. 2,023 funds tracked by Wall St. Rank hold GILD as of Q2 2025.

  • Arvest Investments reported no remaining Gilead Sciences position as of Q2 2025 after selling out during the quarter.
  • Arvest Investments sold 9,027 Gilead Sciences shares in Q2 2025, an estimated $1.01M.
  • Arvest Investments first reported a position in Gilead Sciences in Q4 2023 and held it in 6 quarters.
  • Arvest Investments's Gilead Sciences position peaked at $1.01M in Q1 2025.
  • 2,023 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2025.

Based on Arvest Investments's 13F filing for Q2 2025, filed 3 Jul 2025.